Copyright
©The Author(s) 2017.
World J Gastrointest Pharmacol Ther. Feb 6, 2017; 8(1): 26-38
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.26
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.26
Epidemiology | Type of lesion | Mechanism | |
Typical | |||
Cloropromazine | Jaundice: 0.16%-0.3%[99] Severe DILI: > 350[100,101,115-124] Fatal Injury: 8[102-109] | Cholestatic | Immuno-allergic |
Haloperidol | ALT > 3ULN: 2%[110] Severe DILI: 1[111] | Cholestatic | Immuno-allergic |
Atypical | |||
Clozapine | ALT > 3ULN: 15%[125] Severe DILI: 16[126-140] Fatal Injury: 2[141,142] | Hepatocellular Cholestatic Chronic esteatosis | Immuno-allergic Chronic estatosis |
Olanzapine | ALT > 3ULN: 6%[143] Severe DILI: 7[139,144-149] | Hepatocellular Cholestatic Chronic esteatosis | Immuno-allergic, Chronic estatosis |
Risperidone | ALT > 3ULN: 3%[150] Severe DILI: 13[150-162] | Hepatocellular Cholestatic Chronic esteatosis | Immuno-allergic Chronic estatosis |
Quetiapine | ALT > 3ULN: 0%[143] Severe DILI: 3[151,163,164] Fatal injury: 2[165,166] | ? | ? |
Ziprasidone | Not reported Severe DILI: 1[167] | ? | ? |
Aripiprazole | Not reported | ||
Amissulpride | Not reported |
- Citation: Telles-Correia D, Barbosa A, Cortez-Pinto H, Campos C, Rocha NBF, Machado S. Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity. World J Gastrointest Pharmacol Ther 2017; 8(1): 26-38
- URL: https://www.wjgnet.com/2150-5349/full/v8/i1/26.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v8.i1.26